Charles River Laboratories International CRL
NYSE CRL
$304.73 +5.71 (+1.91%)
As of: Oct 14, 2026 · 12:42 PM EDT

Charles River Laboratories International (CRL) Cost of Revenue (2009 - 2026)

Updated

Charles River Laboratories International (CRL) posted Cost of Revenue of $640.7 million for Q2 2026, down 5.1% from $675.07 million a year earlier and down 8.6% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Cost of Revenue (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 27, 2026, Cost of Revenue at Charles River Laboratories International was $2.69 billion, down 1.0% year-over-year; for FY2025, it was $2.69 billion, down 1.0% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In prior years, Charles River Laboratories International's Cost of Revenue was $2.72 billion in FY2024 (+3.5%), $2.63 billion in FY2023 (+4.5%), $2.51 billion in FY2022 (+14.0%) and $2.21 billion in FY2021 (+19.2%).
  • The Q2 2026 figure stands as the lowest quarterly Cost of Revenue since Q3 2022.
  • On a year-over-year basis, Cost of Revenue increased in four of the last eight quarters, with growth averaging 0.8%.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q4 2022, with growth of 25.6%; the weakest was Q4 2023, with a decline of 7.4%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $701.17 million (Q1 2026), $684.54 million (Q4 2025) and $666.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Iqvia Holdings 43.66 Bn 35.37 Bn 1.44 Bn 2.93 Bn
2 Medpace Holdings 17.37 Bn 15.43 Bn 201.64 Mn 505.69 Mn
3 Charles River Laboratories International 14.62 Bn 13.81 Bn 363.37 Mn 640.70 Mn
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn 1.58 Bn
5 Fortrea Holdings 2.05 Bn 1.42 Bn 139.20 Mn 539.00 Mn
6 Ginkgo Bioworks Holdings 732.40 Mn -29.68 Mn 18.44 Mn 1.72 Mn
7 Evotec SE 507.87 Mn -1.10 Bn - -
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn 7.53 Mn
9 MindWalk Holdings 65.34 Mn 28.99 Mn 1.61 Mn 1.14 Mn
10 Natural Alternatives International 6.69 Mn -21.39 Mn 1.73 Mn 32.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 640.70 Mn
Mar 28, 2026 701.17 Mn
Dec 27, 2025 684.54 Mn
Sep 27, 2025 666.06 Mn
Jun 28, 2025 675.07 Mn
Mar 29, 2025 666.44 Mn
Dec 28, 2024 718.31 Mn
Sep 28, 2024 660.74 Mn
Jun 29, 2024 672.40 Mn
Mar 30, 2024 666.72 Mn
Dec 30, 2023 649.39 Mn
Sep 30, 2023 664.78 Mn
Jul 1, 2023 660.96 Mn
Apr 1, 2023 651.72 Mn
Dec 31, 2022 700.96 Mn
Sep 24, 2022 618.93 Mn
Jun 25, 2022 616.41 Mn
Mar 26, 2022 577.11 Mn
Dec 25, 2021 557.94 Mn
Sep 25, 2021 558.71 Mn
API Access

Charles River Laboratories International Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CRL&period=max&api_key=YOUR_API_KEY